ArticleTranslational andrology and urology2026
DDR2 expression on circulating lymphocytes and monocytes associates with chronic active antibody-mediated rejection in kidney transplant recipients.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic antibody-mediated rejection (AMR) is a leading cause of late kidney allograft loss, yet sensitive non-invasive biomarkers are lacking. Discoidin domain receptor 2 (DDR2), a collagen-binding tyrosine kinase implicated in fibrosis, may play a role in its pathogenesis. This study aimed to investigate the expression and clinical relevance of DDR2 in patients with chronic AMR. Methods: In this single-center study, 76 renal transplant recipients were classified into a chronic active AMR group (n=31) based on Banff 2019 criteria and a control group with normal histology (n=45). DDR2 expression on peripheral blood lymphocytes and monocytes was quantified by flow cytometry. Associations between DDR2 levels and Banff lesion scores were analyzed. Results: Chronic AMR patients exhibited significantly higher proportions of DDR2+ lymphocytes (0.42%±0.42% Conclusions: Upregulated DDR2 expression on circulating lymphocytes and monocytes is associated with biopsy-proven chronic AMR and correlates with key histopathological features of chronic allograft injury, particularly interstitial inflammation, fibrosis, and vasculopathy. These findings suggest DDR2 as a potential peripheral blood biomarker and a contributor to the pathophysiology of chronic AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.